- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 1.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.5M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $50K |
| Capex | Q1 2026 · Mar 31, 2025 | $138K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $64K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$44K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $40K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $47K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.6M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.65M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.81M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.75M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.76M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.93M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.04M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $20.8M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $21.32M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.81 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.59 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.81 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.59 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.44M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$884K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.43M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$859K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.73M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $2.14M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.99M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.79M |
| Revenue | Q1 2026 · Mar 31, 2026 | $6.96M |
| Revenue | Q1 2026 · Mar 31, 2025 | $4.91M |